SCHEMBL692891

SCHEMBL692891

NCC(N)OCCO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1173444 0.82 ALDH1A1 (0.33)
SCHEMBL2891020 0.80
SCHEMBL27618969 0.79
SCHEMBL22283562 0.78
SCHEMBL9656058 0.78
Ethylene Glycol SCHEMBL27361418 0.77 ALDH1A1 (0.32)
SCHEMBL7169036 0.76 TSHR (0.38)
SCHEMBL1449501 0.74
SCHEMBL1499951 0.74 TSHR (0.43)
SCHEMBL27912359 0.74 TSHR (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2519104-B1 PESTICIDAL COMPOSITION SYNGENTA PARTICIPATIONS AG (CH) 2021-03-31 EP claimed
EP-2160383-B1 N, N',N''-TRIMETHYL-N, N', N''-TRIS(METHOXYCARBONYL)-MELAMINE DERIVATIVES AND SIMILAR TRIAZINE DERIVATIVES FOR AS CROSS-LINKERS AND/OR BINDERS IN COATING COMPOUNDS, PAINTS, INKS, COMPOSITE MATERIALS AND LAMINATES BOREALIS AGROLINZ MELAMINE (AT) 2016-03-09 EP claimed
EP-1998870-B2 PROCESS FOR CONTACTING TWO PHASES WHOSE CONTACT IS ACCOMPANIED BY HEAT EVOLUTION BASF SE (DE) 2015-09-02 EP claimed
EP-1998870-B1 PROCESS FOR CONTACTING TWO PHASES WHOSE CONTACT IS ACCOMPANIED BY HEAT EVOLUTION BASF SE (DE) 2012-02-29 EP claimed
EP-3263624-B1 WATER DISPERSION OF GEL PARTICLES, PRODUCING METHOD THEREOF, AND IMAGE FORMING METHOD FUJIFILM CORP (JP) 2022-08-03 EP disclosed
EP-3275904-B1 WATER DISPERSION OF GEL PARTICLES, PRODUCING METHOD THEREOF, AND IMAGE FORMATION METHOD FUJIFILM CORP (JP) 2021-12-01 EP disclosed
CN-107250217-B Water dispersion of gel particles, method for producing same, and image forming method 富士胶片株式会社 2021-06-22 CN disclosed
EP-3275905-B1 WATER DISPERSION OF GEL PARTICLES, PRODUCING METHOD THEREOF, AND IMAGE FORMING METHOD FUJIFILM CORP (JP) 2020-12-02 EP disclosed
US-10208216-B2 Water dispersion of gel particles, producing method thereof, and image forming method FUJIFILM CORPORATION (JP) 2019-02-19 US disclosed
EP-3275904-A1 AQUEOUS DISPERSION OF GEL PARTICLES, METHOD FOR PRODUCING SAME, AND IMAGE FORMATION METHOD FUJIFILM Corporation (JP) 2018-01-31 EP disclosed
EP-3275905-A1 AQUEOUS DISPERSION OF GEL PARTICLES, METHOD FOR PRODUCING SAME, AND IMAGE FORMATION METHOD FUJIFILM Corporation (JP) 2018-01-31 EP disclosed
US-20180022836-A1 WATER DISPERSION OF GEL PARTICLES, PRODUCING METHOD THEREOF, AND IMAGE FORMING METHOD FUJIFILM CORPORATION (JP) 2018-01-25 US disclosed
EP-3263624-A1 AQUEOUS DISPERSION OF GEL PARTICLES, METHOD FOR PRODUCING SAME, AND IMAGE FORMING METHOD Fujifilm Corporation (JP) 2018-01-03 EP disclosed
US-20170349771-A1 WATER DISPERSION OF GEL PARTICLES, PRODUCING METHOD THEREOF, AND IMAGE FORMING METHOD FUJIFILM CORPORATION (JP) 2017-12-07 US disclosed
US-20170342171-A1 WATER DISPERSION OF GEL PARTICLES, PRODUCING METHOD THEREOF, AND IMAGE FORMING METHOD FUJIFILM CORPORATION (JP) 2017-11-30 US disclosed
EP-2794595-B1 HETEROCYCLIC COMPOUNDS, MEDICAMENTS CONTAINING SAID COMPOUNDS, USE THEREOF AND PROCESSES FOR THE PREPARATION THEREOF BOEHRINGER INGELHEIM INT (DE) 2017-08-02 EP disclosed
EP-2794595-A1 HETEROCYCLIC COMPOUNDS, MEDICAMENTS CONTAINING SAID COMPOUNDS, USE THEREOF AND PROCESSES FOR THE PREPARATION THEREOF Boehringer Ingelheim International GmbH (DE) 2014-10-29 EP disclosed
US-8859559-B2 Substituted pyrazines and their use in the treatment of disease BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-10-14 US disclosed
WO-2013092674-A1 HETEROCYCLIC COMPOUNDS, MEDICAMENTS CONTAINING SAID COMPOUNDS, USE THEREOF AND PROCESSES FOR THE PREPARATION THEREOF BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-06-27 WO disclosed
US-20130157981-A1 HETEROCYCLIC COMPOUNDS, MEDICAMENTS CONTAINING SAID COMPOUNDS, USE THEREOF AND PROCESSES FOR THE PREPARATION THEREOF BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-06-20 US disclosed